Skip to main content
Editorial
The never-ending struggle with laboratory testing for Clostridium difficile infection
- Christopher R Polage,
- Joanna V Turkiewicz, and
- Stuart H Cohen
pp113–116
Published Online:1 March 2016
Commentary
Better research reporting to improve the utility of routine data for making better treatment decisions
- Lars G Hemkens,
- Sinéad M Langan, and
- Eric I Benchimol
pp117–122
Published Online:1 March 2016
Patient and clinician support for the learning healthcare system: recommendations for enhancing value
- Rachael M Moloney,
- Ellen S Tambor, and
- Sean R Tunis
pp123–128
Published Online:1 March 2016
Research Article
Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison
- Elyse Swallow,
- Jinlin Song,
- Yong Yuan,
- Anupama Kalsekar,
- Caroline Kelley,
- Fan Mu,
- Soomi Kim,
- Stephanie Noviello, and
- James Signorovitch
pp129–139
Published Online:21 September 2015
Survival in unresectable AJCC stage I and II HCC and the effect of DEB-TACE: SEER versus tertiary cancer center cohort study
- Minzhi Xing,
- Nima Kokabi,
- Hasmukh J Prajapati,
- Orrie Close,
- Johannes M Ludwig, and
- Hyun S Kim
pp141–154
Published Online:7 March 2016
Home-based interventions for black patients with uncontrolled hypertension: a cluster randomized controlled trial
- Penny H Feldman,
- Margaret V McDonald,
- Yolanda Barrón,
- Linda M Gerber, and
- Timothy R Peng
pp155–168
Published Online:7 March 2016
Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
- Pawel Petryszyn,
- Aleksandra Staniak, and
- Jedrzej Grzegrzolka
pp169–178
Published Online:7 March 2016
Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records
- Yen Sia Low,
- Blanca Gallego, and
- Nigam Haresh Shah
pp179–192
Published Online:4 December 2015
Perspective
Improving the relevance and consistency of outcomes in comparative effectiveness research
- Sean R Tunis,
- Mike Clarke,
- Sarah L Gorst,
- Elizabeth Gargon,
- Jane M Blazeby,
- Douglas G Altman, and
- Paula R Williamson
pp193–205
Published Online:1 March 2016
Comparative effectiveness research in the USA: when will there be an impact on healthcare decision-making?
- Kimberly D Westrich,
- Jess A Wilhelm, and
- Claudia L Schur
pp207–216
Published Online:4 February 2016
Review
Comparative effectiveness of primary PCI versus fibrinolytic therapy for ST elevation myocardial infarction: a review of the literature
- Eleanor R Joy,
- John Kurian, and
- Chris P Gale
pp217–226
Published Online:7 March 2016
Corrigendum
Corrigendum
pp228–228
Published Online:8 February 2016
- Correction(s) for this article
Engaging stakeholders to design a comparative effectiveness trial in children with uncontrolled asthma
- Volume 5Issue 1Journal of Comparative Effectiveness Research
- 21 December 2015